JP2009503083A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009503083A5 JP2009503083A5 JP2008525073A JP2008525073A JP2009503083A5 JP 2009503083 A5 JP2009503083 A5 JP 2009503083A5 JP 2008525073 A JP2008525073 A JP 2008525073A JP 2008525073 A JP2008525073 A JP 2008525073A JP 2009503083 A5 JP2009503083 A5 JP 2009503083A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- methyl
- aryl
- oxo
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 52
- 229910052739 hydrogen Inorganic materials 0.000 claims 33
- 239000001257 hydrogen Substances 0.000 claims 33
- 125000003118 aryl group Chemical group 0.000 claims 32
- 125000000623 heterocyclic group Chemical group 0.000 claims 21
- 150000002431 hydrogen Chemical class 0.000 claims 19
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 12
- 229910052736 halogen Inorganic materials 0.000 claims 12
- 150000002367 halogens Chemical class 0.000 claims 12
- -1 {2-[({7-[(4-Fluorophenyl) methyl] -4-hydroxy-2-oxo-1,2-dihydro-1,5-naphthyridin-3-yl} carbonyl) amino] ethyl} phosphonic acid Chemical compound 0.000 claims 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 9
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 9
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 8
- 125000000304 alkynyl group Chemical group 0.000 claims 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims 8
- 125000006648 (C1-C8) haloalkyl group Chemical group 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 125000001424 substituent group Chemical group 0.000 claims 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 5
- 125000005842 heteroatom Chemical group 0.000 claims 5
- 125000003627 8 membered carbocyclic group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 claims 1
- ZPSJPGHVLDDZQL-UHFFFAOYSA-N 2-[[7-[(4-fluorophenyl)methyl]-4-hydroxy-1-methyl-2-oxo-1,5-naphthyridine-3-carbonyl]amino]ethylphosphonic acid Chemical compound C=1N=C2C(O)=C(C(=O)NCCP(O)(O)=O)C(=O)N(C)C2=CC=1CC1=CC=C(F)C=C1 ZPSJPGHVLDDZQL-UHFFFAOYSA-N 0.000 claims 1
- MJMVUVWSSYDFPO-UHFFFAOYSA-N 3-[[7-[(4-fluorophenyl)methyl]-4-hydroxy-1-methyl-2-oxo-1,5-naphthyridine-3-carbonyl]amino]propylphosphonic acid Chemical compound C=1N=C2C(O)=C(C(=O)NCCCP(O)(O)=O)C(=O)N(C)C2=CC=1CC1=CC=C(F)C=C1 MJMVUVWSSYDFPO-UHFFFAOYSA-N 0.000 claims 1
- QRVYMDVCVWYGAU-UHFFFAOYSA-N 4-[2-[7-[(4-fluorophenyl)methyl]-4-hydroxy-2-oxo-3-(phosphonomethylcarbamoyl)-1,5-naphthyridin-1-yl]ethylamino]butanoic acid Chemical compound C=1N=C2C(O)=C(C(=O)NCP(O)(O)=O)C(=O)N(CCNCCCC(=O)O)C2=CC=1CC1=CC=C(F)C=C1 QRVYMDVCVWYGAU-UHFFFAOYSA-N 0.000 claims 1
- NIPVCGHZPVBSPW-UHFFFAOYSA-N 4-[[7-[(4-fluorophenyl)methyl]-4-hydroxy-1-methyl-2-oxo-1,5-naphthyridine-3-carbonyl]amino]butylphosphonic acid Chemical compound C=1N=C2C(O)=C(C(=O)NCCCCP(O)(O)=O)C(=O)N(C)C2=CC=1CC1=CC=C(F)C=C1 NIPVCGHZPVBSPW-UHFFFAOYSA-N 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- PTQIMVFKAJIPCV-UHFFFAOYSA-N [[7-[(4-fluorophenyl)methyl]-4-hydroxy-1-methyl-2-oxo-1,5-naphthyridine-3-carbonyl]amino]methylphosphonic acid Chemical compound C=1N=C2C(O)=C(C(=O)NCP(O)(O)=O)C(=O)N(C)C2=CC=1CC1=CC=C(F)C=C1 PTQIMVFKAJIPCV-UHFFFAOYSA-N 0.000 claims 1
- GUNLZIOBCDJRJM-UHFFFAOYSA-N [[7-[(4-fluorophenyl)methyl]-4-hydroxy-2-oxo-1-[2-(2-oxopyrrolidin-1-yl)ethyl]-1,5-naphthyridine-3-carbonyl]amino]methylphosphonic acid Chemical compound C12=CC(CC=3C=CC(F)=CC=3)=CN=C2C(O)=C(C(=O)NCP(O)(O)=O)C(=O)N1CCN1CCCC1=O GUNLZIOBCDJRJM-UHFFFAOYSA-N 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000002651 drug therapy Methods 0.000 claims 1
- 125000001188 haloalkyl group Chemical group 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000005541 phosphonamide group Chemical group 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70532805P | 2005-08-04 | 2005-08-04 | |
| PCT/US2006/029652 WO2007019101A2 (en) | 2005-08-04 | 2006-07-28 | Hiv integrase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009503083A JP2009503083A (ja) | 2009-01-29 |
| JP2009503083A5 true JP2009503083A5 (enExample) | 2009-09-10 |
Family
ID=37727849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008525073A Pending JP2009503083A (ja) | 2005-08-04 | 2006-07-28 | Hivインテグラーゼ阻害薬 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20080214503A1 (enExample) |
| EP (1) | EP1910356A4 (enExample) |
| JP (1) | JP2009503083A (enExample) |
| WO (1) | WO2007019101A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010011959A1 (en) * | 2008-07-25 | 2010-01-28 | Gilead Sciences, Inc. | Antiviral compounds |
| US8283366B2 (en) | 2010-01-22 | 2012-10-09 | Ambrilia Biopharma, Inc. | Derivatives of pyridoxine for inhibiting HIV integrase |
| WO2014047562A2 (en) * | 2012-09-21 | 2014-03-27 | Epiphany Biosciences | Method of treating and/or preventing shingles and method of treating and/or preventing zoster associated pain |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6225318B1 (en) * | 1996-10-17 | 2001-05-01 | Pfizer Inc | 4-aminoquinazolone derivatives |
| AU1532802A (en) * | 2000-10-12 | 2002-04-22 | Merck & Co Inc | Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| ATE430745T1 (de) * | 2000-10-12 | 2009-05-15 | Merck & Co Inc | Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase |
| ES2291642T3 (es) * | 2002-01-17 | 2008-03-01 | MERCK & CO., INC. | Hidroxinaftiridinoncarboxamidas utiles como inhibidores de la integrasa de vih. |
| DE60322920D1 (de) * | 2002-08-13 | 2008-09-25 | Shionogi & Co | Heterocyclische verbindungen mit hiv-integrase-hemmender wirkung |
| TW200505902A (en) * | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
| WO2005028478A1 (en) * | 2003-09-19 | 2005-03-31 | Gilead Sciences, Inc. | Aza-quinolinol phosphonate integrase inhibitor compounds |
| EP1720856B1 (en) * | 2004-02-11 | 2013-08-14 | GlaxoSmithKline LLC | Hiv integrase inhibitors |
-
2006
- 2006-07-28 JP JP2008525073A patent/JP2009503083A/ja active Pending
- 2006-07-28 WO PCT/US2006/029652 patent/WO2007019101A2/en not_active Ceased
- 2006-07-28 US US11/997,780 patent/US20080214503A1/en not_active Abandoned
- 2006-07-28 EP EP06800522A patent/EP1910356A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013544276A5 (enExample) | ||
| JP2007517807A5 (enExample) | ||
| JP2018502101A5 (enExample) | ||
| RU2004104625A (ru) | Аналоги простагландинов в качестве агонистов рецептора ep4 | |
| JP2013532652A5 (enExample) | ||
| JP2014500295A5 (enExample) | ||
| JP2006524660A5 (enExample) | ||
| RU2005123485A (ru) | Производные фосфонооксихиназолина и их фармацевтическое применение | |
| JP2009504763A5 (enExample) | ||
| JP2013509392A5 (enExample) | ||
| JP2010529147A5 (enExample) | ||
| RU2011136537A (ru) | Кристаллическая форма (r)-3-(4-(2-метилтетразол-5-ил)пиридин-5-ил)-3-фторфенил)-5-гидроксиметил оксазолидин-2-он диводород фосфата | |
| JP2006501201A5 (enExample) | ||
| JP2008535803A5 (enExample) | ||
| JP2012510502A5 (enExample) | ||
| JP2011505347A5 (enExample) | ||
| JP2010513434A5 (enExample) | ||
| JP2011507896A5 (enExample) | ||
| JP2009538910A5 (enExample) | ||
| JP2014500265A5 (enExample) | ||
| JP2007507494A5 (enExample) | ||
| RU2004100843A (ru) | Производные имидазола, модулирующие натриевые каналы | |
| JP2004532240A5 (enExample) | ||
| JP2002505286A5 (enExample) | ||
| JP2018530582A5 (enExample) |